Peter Couroux

Mississauga, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin.

A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin.

Journal: Clinical and translational science

Published: February 11, 2022

Safety of the standardized quality tree sublingual immunotherapy tablet: Pooled safety analysis of clinical trials.

Safety of the standardized quality tree sublingual immunotherapy tablet: Pooled safety analysis of clinical trials.

Journal: Allergy

Published: September 25, 2020

Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergen.

Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergen.

Journal: The Journal of allergy and clinical immunology

Published: October 15, 2019

First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis.

First clinical trials of novel ENaC targeting therapy, SPX-101, in healthy volunteers and adults with cystic fibrosis.

Journal: Pulmonary pharmacology & therapeutics

Published: March 20, 2019

A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG4 to allergens from all trees in the birch homologous group.

A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG4 to allergens from all trees in the birch homologous group.

Journal: Allergy

Published: July 24, 2018

Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.

Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.

Journal: The journal of allergy and clinical immunology. In practice

Published: November 10, 2017

Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.

Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: September 17, 2014

Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis.

Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis.

Journal: The Journal of allergy and clinical immunology

Published: April 23, 2013

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study.

Journal: The Journal of allergy and clinical immunology

Published: March 01, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026